The relationship between ferrokinetic parameters and the state of cardiac remodeling in patients with coronary artery disease with concomitant iron deficiency
DOI:
https://doi.org/10.14739/2310-1237.2023.1.275370Keywords:
coronary artery disease, iron deficiency, ferrokinetic parameters, cardiac remodelingAbstract
The aim of the study: to assess the relationship between ferrokinetic parameters and the state of cardiac remodeling in patients with coronary artery disease (CAD) depending on the stage of iron deficiency (ID).
Materials and methods. The study involved 90 patients with CAD: stable angina pectoris II–III FC (35 men and 55 women, age – 69 (61; 72) years). All patients were divided into 4 clinical groups depending on the parameters of iron metabolism and hemogram: I (n = 16) – patients with absolute ID; II (n = 15) – with latent ID; III (n = 14) – with functional ID; IV (n = 45) – patients with CAD without iron metabolism disorders. The parameters of cardiac remodeling, iron metabolism and their relationship were analyzed.
Results. During the analysis of ferrokinetic parameters, a decrease in transport (serum iron, transferrin saturation) and tissue (ferritin) reserve of iron on the background of an increase in the total and latent iron-binding capacity depending on the stage of sideropenia was established. At the same time, latent iron-binding capacity in patients with absolute ID was less by 43 % than in patients with latent ID. Patients with latent ID demonstrated a significantly higher level of transferrin saturation by 59.9 % than in the group of patients with CAD without concomitant ID. Patients with absolute ID, compared to patients without iron metabolism disorders, demonstrated significantly higher size of RAd by 14.18 % (U = 2.0; p < 0.05); increase EDVI of LV in 1.7 times (U = 4.0; p < 0.05); higher value of LV MI by 16 % (U = 17.0; p < 0.05). Also, patients with ferrokinetics disorders demonstrated a tendency to increase LVIDd, EDV LV, ESV LV, ESVI, LV mass, Ao, RAd, RVd, IVSd compared to patients without concomitant ID. For patients with absolute ID, it was established that there a relationship between the level of ferritin and IVSd (r = +0.84; p < 0.05); serum iron and LAd (r = -0.73; p < 0.05); total iron-binding capacity and Ao (r = -0.78; p < 0.05); latent iron-binding capacity and LVIDs (r = +0.71; p < 0.05). Patients with latent ID demonstrated relationships only between the transferrin saturation and LV MI (r = +0.60; p < 0.05). There were no statistically significant correlation relationships between indicators of iron metabolism and cardiac remodeling in patients with CAD and functional ID.
Conclusions. The intensity of the processes of cardiac remodeling in patients with CAD and iron deficiency increases in direct proportion to the degree of progression of sideropenia, what is confirmed by the relevant correlation relationships.
References
Sirenko, Yu. M. (2022). Stan problemy sertsevo-sudynnoi zakhvoriuvanosti ta smertnosti v Ukraini [The state of the problem of cardiovascular morbidity and mortality in Ukraine]. Liky Ukrainy, (2), 11-14. [in Ukrainian]. https://doi.org/10.37987/1997-9894.2022.2(258).264084
Kotseva, K., De Backer, G., De Bacquer, D., Rydén, L., Hoes, A., Grobbee, D., Maggioni, A., Marques-Vidal, P., Jennings, C., Abreu, A., Aguiar, C., Badariene, J., Bruthans, J., Cifkova, R., Davletov, K., Dilic, M., Dolzhenko, M., Gaita, D., Gotcheva, N., Hasan-Ali, H., … EUROASPIRE V Investigators (2021). Primary prevention efforts are poorly developed in people at high cardiovascular risk: A report from the European Society of Cardiology EURObservational Research Programme EUROASPIRE V survey in 16 European countries. European journal of preventive cardiology, 28(4), 370-379. https://doi.org/10.1177/2047487320908698
Gupta, P. M., Hamner, H. C., Suchdev, P. S., Flores-Ayala, R., & Mei, Z. (2017). Iron status of toddlers, nonpregnant females, and pregnant females in the United States. The American journal of clinical nutrition, 106(Suppl 6), 1640S-1646S. https://doi.org/10.3945/ajcn.117.155978
Koval, O. A. (2020). Diahnostyka ta korektsiia zalizodefitsytnykh staniv u patsiientiv iz sertsevo-sudynnymy zakhvoriuvanniamy [Diagnosis and correction of iron deficiency conditions in patients with cardiovascular diseases]. Zdorovia Ukrainy, (4), 44-45. [in Ukrainian].
Schrage, B., Rübsamen, N., Ojeda, F. M., Thorand, B., Peters, A., Koenig, W., Söderberg, S., Söderberg, M., Mathiesen, E. B., Njølstad, I., Kee, F., Linneberg, A., Kuulasmaa, K., Tarja, P., Salomaa, V., Blankenberg, S., Zeller, T., & Karakas, M. (2021). Association of iron deficiency with incident cardiovascular diseases and mortality in the general population. ESC heart failure, 8(6), 4584-4592. https://doi.org/10.1002/ehf2.13589
Kondratiuk, V. K., & Kondratiuk, K. O. (2021). Zalizodefitsytni stany kriz pryzmu dokazovoi medytsyny [Iron deficiency states through the prism of evidence-based medicine]. Zdorovia Ukrainy 21 storichchia, (9), 12-13. [in Ukrainian].
Tsyhanenko, I. V., Ovcharenko, L. K., & Zaiats, Yu. B. (2022). Anemiia, yak faktor sertsevo-sudynnoho ryzyku na prykladi patsiientiv z khronichnoiu sertsevoiu nedostatnistiu [Anemia as a Cardiovascular Risk Factor in Patients with Chronic Heart Failure]. Ukrainskyi zhurnal medytsyny, biolohii ta sportu, (3), 200-205. [in Ukrainian]. https://doi.org/10.26693/jmbs07.03.200
Snook, J., Bhala, N., Beales, I. L. P., Cannings, D., Kightley, C., Logan, R. P., Pritchard, D. M., Sidhu, R., Surgenor, S., Thomas, W., Verma, A. M., & Goddard, A. F. (2021). British Society of Gastroenterology guidelines for the management of iron deficiency anaemia in adults. Gut, 70(11), 2030-2051. https://doi.org/10.1136/gutjnl-2021-325210
Ministry of Health of Ukraine. (2015, Nowember 2). Unifikovanyi klinichnyi protokol pervynnoi ta vtorynnoi (spetsializovanoi) medychnoi dopomohy. Zalizodefitsytna anemiia. Nakaz Ministerstva okhorony zdorovia Ukrainy vid 02.11.2020 № 709. [Unified clinical protocol for primary, secondary (specialized) care: iron deficiency anemia (No. 709)]. https://zakon.rada.gov.ua/rada/show/v0709282-15#Text
Weiss, G., Ganz, T., & Goodnough, L. T. (2019). Anemia of inflammation. Blood, 133(1), 40-50. https://doi.org/10.1182/blood-2018-06-856500
Auerbach, M., & Spivak, J. (2019). Treatment of Iron Deficiency in the Elderly: A New Paradigm. Clinics in geriatric medicine, 35(3), 307-317. https://doi.org/10.1016/j.cger.2019.03.003
Tatarchuk, T. F. (2020). “Masky” latentnoho zalizodefitsytu: syndrom khronichnoi vtomy ta retsydyvuiuchi infektsii statevykh shliakhiv [“Masks” of latent iron deficiency: chronic fatigue syndrome and recurrent infections of the genital tract]. Akusherstvo, Hinekolohiia, Reproduktolohiia, (5), 11. [in Ukrainian].
Ruhe, J., Waldeyer, C., Ojeda, F., Altay, A., Schnabel, R. B., Schäfer, S., Lackner, K. J., Blankenberg, S., Zeller, T., & Karakas, M. (2018). Intrinsic Iron Release Is Associated with Lower Mortality in Patients with Stable Coronary Artery Disease-First Report on the Prospective Relevance of Intrinsic Iron Release. Biomolecules, 8(3), 72. https://doi.org/10.3390/biom8030072
Zeller, T., Waldeyer, C., Ojeda, F., Schnabel, R. B., Schäfer, S., Altay, A., Lackner, K. J., Anker, S. D., Westermann, D., Blankenberg, S., & Karakas, M. (2018). Adverse Outcome Prediction of Iron Deficiency in Patients with Acute Coronary Syndrome. Biomolecules, 8(3), 60. https://doi.org/10.3390/biom8030060
Alnuwaysir, R. I. S., Hoes, M. F., van Veldhuisen, D. J., van der Meer, P., & Grote Beverborg, N. (2021). Iron Deficiency in Heart Failure: Mechanisms and Pathophysiology. Journal of clinical medicine, 11(1), 125. https://doi.org/10.3390/jcm11010125
Moliner, P., Enjuanes, C., Tajes, M., Cainzos-Achirica, M., Lupón, J., Garay, A., Jimenez-Marrero, S., Yun, S., Farré, N., Cladellas, M., Díez, C., Gonzalez-Costello, J., & Comin-Colet, J. (2019). Association Between Norepinephrine Levels and Abnormal Iron Status in Patients With Chronic Heart Failure: Is Iron Deficiency More Than a Comorbidity?. Journal of the American Heart Association, 8(4), e010887. https://doi.org/10.1161/JAHA.118.010887
Núñez, J., Miñana, G., Cardells, I., Palau, P., Llàcer, P., Fácila, L., Almenar, L., López-Lereu, M. P., Monmeneu, J. V., Amiguet, M., González, J., Serrano, A., Montagud, V., López-Vilella, R., Valero, E., García-Blas, S., Bodí, V., de la Espriella-Juan, R., Lupón, J., Navarro, J., … Myocardial-IRON Investigators* † (2020). Noninvasive Imaging Estimation of Myocardial Iron Repletion Following Administration of Intravenous Iron: The Myocardial-IRON Trial. Journal of the American Heart Association, 9(4), e014254. https://doi.org/10.1161/JAHA.119.014254
Ambrosy, A. P., Gurwitz, J. H., Tabada, G. H., Artz, A., Schrier, S., Rao, S. V., Barnhart, H. X., Reynolds, K., Smith, D. H., Peterson, P. N., Sung, S. H., Cohen, H. J., Go, A. S., & RBC HEART Investigators (2019). Incident anaemia in older adults with heart failure: rate, aetiology, and association with outcomes. European heart journal. Quality of care & clinical outcomes, 5(4), 361-369. https://doi.org/10.1093/ehjqcco/qcz010
Alnuwaysir, R. I. S., Hoes, M. F., van Veldhuisen, D. J., van der Meer, P., & Grote Beverborg, N. (2021). Iron Deficiency in Heart Failure: Mechanisms and Pathophysiology. Journal of clinical medicine, 11(1), 125. https://doi.org/10.3390/jcm11010125
Núñez, J., Miñana, G., Cardells, I., Palau, P., Llàcer, P., Fácila, L., Almenar, L., López-Lereu, M. P., Monmeneu, J. V., Amiguet, M., González, J., Serrano, A., Montagud, V., López-Vilella, R., Valero, E., García-Blas, S., Bodí, V., de la Espriella-Juan, R., Lupón, J., Navarro, J., … Myocardial-IRON Investigators* † (2020). Noninvasive Imaging Estimation of Myocardial Iron Repletion Following Administration of Intravenous Iron: The Myocardial-IRON Trial. Journal of the American Heart Association, 9(4), e014254. https://doi.org/10.1161/JAHA.119.014254
Sutil-Vega, M., Rizzo, M., & Martínez-Rubio, A. (2019). Anemia and iron deficiency in heart failure: a review of echocardiographic features. Echocardiography, 36(3), 585-594. https://doi.org/10.1111/echo.14271
Schwartz, A. J., Converso-Baran, K., Michele, D. E., & Shah, Y. M. (2019). A genetic mouse model of severe iron deficiency anemia reveals tissue-specific transcriptional stress responses and cardiac remodeling. The Journal of biological chemistry, 294(41), 14991-15002. https://doi.org/10.1074/jbc.RA119.009578
Rineau, E., Gaillard, T., Gueguen, N., Procaccio, V., Henrion, D., Prunier, F., & Lasocki, S. (2018). Iron deficiency without anemia is responsible for decreased left ventricular function and reduced mitochondrial complex I activity in a mouse model. International journal of cardiology, 266, 206-212. https://doi.org/10.1016/j.ijcard.2018.02.021
Haddad, S., Wang, Y., Galy, B., Korf-Klingebiel, M., Hirsch, V., Baru, A. M., Rostami, F., Reboll, M. R., Heineke, J., Flögel, U., Groos, S., Renner, A., Toischer, K., Zimmermann, F., Engeli, S., Jordan, J., Bauersachs, J., Hentze, M. W., Wollert, K. C., & Kempf, T. (2017). Iron-regulatory proteins secure iron availability in cardiomyocytes to prevent heart failure. European heart journal, 38(5), 362-372. https://doi.org/10.1093/eurheartj/ehw333
Anker, S. D., Kirwan, B. A., van Veldhuisen, D. J., Filippatos, G., Comin-Colet, J., Ruschitzka, F., Lüscher, T. F., Arutyunov, G. P., Motro, M., Mori, C., Roubert, B., Pocock, S. J., & Ponikowski, P. (2018). Effects of ferric carboxymaltose on hospitalisations and mortality rates in iron-deficient heart failure patients: an individual patient data meta-analysis. European journal of heart failure, 20(1), 125-133. https://doi.org/10.1002/ejhf.823
Balendran, S., & Forsyth, C. (2021). Non-anaemic iron deficiency. Australian prescriber, 44(6), 193-196. https://doi.org/10.18773/austprescr.2021.052
Savarese, G., von Haehling, S., Butler, J., Cleland, J. G. F., Ponikowski, P., & Anker, S. D. (2023). Iron deficiency and cardiovascular disease. European heart journal, 44(1), 14-27. https://doi.org/10.1093/eurheartj/ehac569
Martens, P. (2022). The Effect of Iron Deficiency on Cardiac Function and Structure in Heart Failure with Reduced Ejection Fraction. Cardiac failure review, 8, e06. https://doi.org/10.15420/cfr.2021.26
Xu, H. Y., Yang, Z. G., Li, R., Shi, K., Zhang, Y., Li, Z. L., Xia, C. C., Peng, W. L., Chen, Q. Y., & Guo, Y. K. (2017). Myocardial Iron Deficiency in Hemodialysis-Dependent End-Stage Renal Disease Patients Undergoing Oral Iron Therapy. Journal of the American College of Cardiology, 70(19), 2455-2456. https://doi.org/10.1016/j.jacc.2017.09.013
Melenovsky, V., Petrak, J., Mracek, T., Benes, J., Borlaug, B. A., Nuskova, H., Pluhacek, T., Spatenka, J., Kovalcikova, J., Drahota, Z., Kautzner, J., Pirk, J., & Houstek, J. (2017). Myocardial iron content and mitochondrial function in human heart failure: a direct tissue analysis. European journal of heart failure, 19(4), 522-530. https://doi.org/10.1002/ejhf.640
Kitamura, N., Yokoyama, Y., Taoka, H., Nagano, U., Hosoda, S., Taworntawat, T., Nakamura, A., Ogawa, Y., Tsubota, K., & Watanabe, M. (2021). Iron supplementation regulates the progression of high fat diet induced obesity and hepatic steatosis via mitochondrial signaling pathways. Scientific reports, 11(1), 10753. https://doi.org/10.1038/s41598-021-89673-8
Chung, Y. J., Swietach, P., Curtis, M. K., Ball, V., Robbins, P. A., & Lakhal-Littleton, S. (2021). Iron-Deficiency Anemia Results in Transcriptional and Metabolic Remodeling in the Heart Toward a Glycolytic Phenotype. Frontiers in cardiovascular medicine, 7, 616920. https://doi.org/10.3389/fcvm.2020.616920
Biegus, J., Zymliński, R., Sokolski, M., Jankowska, E. A., Banasiak, W., & Ponikowski, P. (2019). Elevated lactate in acute heart failure patients with intracellular iron deficiency as identifier of poor outcome. Kardiologia polska, 77(3), 347-354. https://doi.org/10.5603/KP.a2019.0014
Petrak, J., Havlenova, T., Krijt, M., Behounek, M., Franekova, J., Cervenka, L., Pluhacek, T., Vyoral, D., & Melenovsky, V. (2019). Myocardial iron homeostasis and hepcidin expression in a rat model of heart failure at different levels of dietary iron intake. Biochimica et biophysica acta. General subjects, 1863(4), 703-713. https://doi.org/10.1016/j.bbagen.2019.01.010
Chen, Y., Wan, J., Xia, H., Li, Y., Xu, Y., Lin, H., & Iftikhar, H. (2020). Total iron binding capacity (TIBC) is a potential biomarker of left ventricular remodelling for patients with iron deficiency anaemia. BMC cardiovascular disorders, 20(1), 4. https://doi.org/10.1186/s12872-019-01320-3
Downloads
Published
How to Cite
Issue
Section
License
Authors who publish with this journal agree to the following terms:- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (SeeThe Effect of Open Access).
